Mike Halpin
About Mike Halpin
Mike Halpin - Vericel Chief Operating Officer
Mike Halpin has been serving as the Chief Operating Officer at Vericel since April 2017. His role involves overseeing various operational aspects of the company, leveraging his extensive expertise in regulatory, quality assurance, and clinical research. Throughout his tenure, Halpin has contributed significantly to the company's strategic and operational initiatives, ensuring compliance with industry standards and enhancing process efficiencies.
Mike Halpin's Professional Background and Experience
With over 28 years of experience in regulatory, quality assurance, and clinical research, Mike Halpin has amassed a wealth of knowledge in the medical device and advanced therapy technology sectors. His career includes significant roles at Sanofi and Genzyme Corporation, where he held the position of vice president and North American region regulatory head. During his time at Genzyme, Halpin was vice president of regulatory affairs for the biosurgery division, overseeing products such as Carticel, Epicel, and MACI. Additionally, he has held various regulatory, quality, and clinical affairs positions at notable companies, including Abbott/MediSense, C.R. Bard, and Abiomed.
Regulatory Leadership at Genzyme Corporation
Before joining Vericel, Mike Halpin worked at Genzyme Corporation, where he served as vice president of regulatory affairs for the biosurgery division. In this role, he had regulatory oversight over all biosurgery and cell and gene therapy products, including key products such as Carticel, Epicel, and MACI. His leadership ensured that these products met regulatory standards and contributed to their successful market positioning.
Mike Halpin's Education in Biomedical Engineering and Biochemistry
Mike Halpin holds a master's degree in biomedical engineering and a bachelor's degree in biochemistry, both from the University of Virginia. His academic background provided a strong foundation for his extensive career in regulatory, quality assurance, and clinical research within the medical device and biosurgery fields. Halpin's education has equipped him with the necessary technical knowledge to navigate the complexities of advanced therapy technologies.